Navigation Links
Genetically modified cell procedure may prove useful in treating kidney failure
Date:6/22/2010

INDIANAPOLIS A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure.

Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein. The research suggests there could be a potential future treatment using such cells delivered intravenously instead of surgically.

Hospital health care professionals must deal with such renal problems during which the kidneys cannot adequately perform their critical roles of removing bodily waste in about five percent of all patients, and a much higher percentage of patients in intensive care units.

IU scientists Jesus Dominguez, M.D., and Katherine Kelly, M.D., report in the August issue of the American Journal of Physiology - Renal Physiology, available online, that they were able to treat acute kidney failure in animal models using cells modified to produce a protein that normally is found when kidneys first develop in embryos. That protein, called SAA, also is produced by the liver in periods of bodily stress, such as during infections, fever or surgery.

In earlier research they had found that applying the SAA protein directly to kidney cells caused those cells to produce tubules like those found in normal kidneys to remove waste products from the blood. Tests determined that the tubules were functional.

The next step was to test whether the protein could have a similar impact in living animals. However, the protein is not easily available, so the researchers modified kidney cells to produce the protein. When the cells were infused into rats with renal failure, their kidney function improved quickly and significantly, the researchers found.

"In other studies, protecting the kidney usually doesn't work after the injury has begun," said Dr. Kelly, assistant professor of medicine. "But this is a significant degree of protection of the kidney, especially for something given after the fact."

In addition, using images from the Indiana Center for Biological Microscopy, the researchers discovered that the infused cells integrated themselves into the kidneys, which showed much less physical damage than the untreated kidneys.

"Now we know that cells can be modified and made to integrate into the kidney from a long distance. So we can give the cells from a peripheral vein and they will go to the kidney and build up, from the inside out. So our model seems to be developing into a transplant model," said Dr. Dominguez, professor of medicine and a physician at the Roudebush VA Medical Center.


'/>"/>

Contact: Eric Schoch
eschoch@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert  

Related biology news :

1. UT Southwestern researchers use novel sperm stem-cell technique to produce genetically modified rats
2. Genetically engineered crops benefit many farmers, but the technology needs proper management to remain effective
3. Genetically engineered tobacco plant cleans up environmental toxin
4. Genetically-modified mice reveal another mechanism contributing to heart failure
5. New study reveals first ever method to genetically identify all 8 tuna species
6. First genetically-engineered malaria vaccine to enter human trials
7. Genetically engineered mice yield clues to knocking out cancer
8. Genetically corrected blood cells obtained from skin cells from Fanconi anemia patients
9. Weed resistance to glyphosate in genetically modified soybean cultivation in Argentina
10. Origins of wolverine in California genetically verified
11. Cats eye diseases genetically linked to diseases in humans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetically modified cell procedure may prove useful in treating kidney failure
(Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
Breaking Biology Technology: